万孚生物：2025年前三季度净利润约1.34亿元

Company Performance - Wanfu Biological (SZ 300482) reported Q3 performance on October 26, with revenue for the first three quarters of 2025 approximately 1.69 billion yuan, a year-on-year decrease of 22.52% [1] - The net profit attributable to shareholders was about 134 million yuan, down 69.32% year-on-year [1] - Basic earnings per share were 0.28 yuan, reflecting a decrease of 70.21% compared to the previous year [1] Market Capitalization - As of the report, Wanfu Biological's market capitalization stands at 10.3 billion yuan [1]